BridgeBio Pharma, Inc. (BBIO)

64.48 -2.00 (-3.01%) USD  |  NASDAQ  |  Mar 02, 12:16
More

BridgeBio Pharma Reconciled Depreciation (Quarterly)

Reconciled Depreciation (Quarterly) Chart

View Reconciled Depreciation (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Reconciled Depreciation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Reconciled Depreciation (Quarterly) Range, Past 5 Years

View Reconciled Depreciation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Reconciled Depreciation (Quarterly) Benchmarks

View Reconciled Depreciation (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade